Incidence and types of malignancies in renal transplant recipients in Iraq.
We retrospectively reviewed the records of 273 renal transplant recipients who received allograft transplants between 1994 and 2004 and recorded the incidence and types of de novo malignancies that developed in these patients. The study was carried out at the Al-karama and Al-rasheed kidney transplant centers in Baghdad, Iraq. A total of 16 patients developed malignancies. The tumors included Kaposi's sarcoma (KS) in eight patients, squamous cell carcinoma (SCC) in four, basal cell carcinoma (BCC) in two and both renal cell carcinoma of the allograft and brain tumor in one patient. Thus, KS was the most common malignancy encountered in our series, with a prevalence of 2.9%, followed by SCC observed in 1.5% and BCC found in 0.7% of the patients. The average latency period between transplantation and development of malignancy was 6.5 months for KS, 3.0 months for SCC and 8.5 months for BCC. To our knowledge, this is the first long-term follow-up study for malignant complications identified in kidney recipients in Iraq.
Altaee
Iqdam K
IK
Department of Urology and Kidney Transplantation, Al-Karama Teaching Hospital - Kidney Transplantation Center, Baghdad, Iraq. driqdam@yahoo.com
Jaleel
Nedham A
NA
Aljubury
Harith M
HM
Alshamaa
Ihsan A
IA
Gazala
Shawqi
S
D000293:Adolescent; D000328:Adult; D002280:Basal Cell Carcinoma / Q000453:epidemiology* / Q000473:pathology; D002294:Carcinoma, Squamous Cell / Q000453:epidemiology* / Q000473:pathology; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D015994:Incidence; D007493:Iraq / Q000453:epidemiology; D007680:Kidney Neoplasms / Q000453:epidemiology* / Q000473:pathology; D016030:Kidney Transplantation; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D011379:Prognosis; D012189:Retrospective Studies; D012514:Sarcoma, Kaposi / Q000453:epidemiology* / Q000473:pathology; D012878:Skin Neoplasms / Q000453:epidemiology* / Q000473:pathology